Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes.
about
Hepatic steatosis: a benign disease or a silent killerHepatitis C virus and type 2 diabetesHepatitis C Virus, Insulin Resistance, and SteatosisHepatitis C and insulin action: An intimate relationshipHepatitis C virus infection and type 1 and type 2 diabetes mellitusReview article: HCV genotype 3 – the new treatment challengeHepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis CSTEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Molecular mechanisms of insulin resistance in chronic hepatitis CHepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathwayHepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control StudyReversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Hepatitis C virus associated glomerulopathies.Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitizationComplementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolismMechanisms and significance of liver steatosis in hepatitis C virus infectionAdenovirus infection results in alterations of insulin signaling and glucose homeostasis.Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infectionOn-site Basic Health Screening and Brief Health Counseling of Chronic Medical Conditions for Veterans in Methadone Maintenance TreatmentThe double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cellsAssociation of metabolic syndrome with development of new-onset diabetes after transplantation.Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes.The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection.Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infectionEffects of GLUT4 expression on insulin resistance in patients with advanced liver cirrhosis.Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stressComparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicityTo study the prevalence of impaired glucose tolerance in patients with hepatitis C virus related chronic liver disease.Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy.Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistanceAssessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action.Diabetes and Hepatitis C: A Two-Way Association.
P2860
Q22305506-6FCFF4DC-931A-45BD-8D82-3AE380A487A9Q24658049-FBDA8F8A-E32F-4A0B-AE00-4F5E9D96F299Q26751755-751F40EC-8A08-40FF-A97A-D09202B53734Q26775000-CB1276C7-0531-4773-9341-4D086F928246Q26829202-1B9D833F-5E74-4F15-8D1F-ABF084093263Q26864571-3DC2BCF8-6DE6-4A51-9752-726AA5CB339FQ27477554-5979B1E9-8FCF-4545-9D3A-AF98E4C027A1Q27477981-7ADC6A95-FCD6-4A8B-B3EE-E31AB3A1D890Q27478329-BAEDA3D0-B04C-44AA-AA97-D02E16880056Q27489665-E720A5ED-73B4-4394-8C4B-A47B1D6A9718Q28728915-F5EE5408-282A-454D-A178-8D966325EA4FQ30360538-6DEAF3C7-4029-4AA5-9FDD-A02BDA8C7A1DQ30369757-F13122D5-EC0F-44E7-8B25-1BD26D528E82Q30395512-9CF325B8-0C12-492D-B87C-4F1D74773D5DQ30422090-AC067EB7-FE57-411F-81DD-2CB3CA58EAF1Q33731308-6AED88E4-8FAC-44EB-BAC5-A1EC53FF3287Q33801278-CDEB4A52-F03A-453D-BEE5-3EC06C6A8136Q33812148-4A8B6DCB-AC3E-4F6F-ADE1-45A13EA70E14Q33830715-CCBFB6FF-8092-470D-83A0-62344D7AAF43Q33866272-43593B0F-D55B-4636-BB66-4689510FDF37Q33916572-118D6306-0117-4906-9556-971631A3B48EQ33998662-27A372C8-5E2E-4FC9-A4D3-923049381F7FQ34093399-4D0DD040-0991-45F3-BBD7-1945B5BA7F6DQ34163416-C4C19420-1015-4ABB-B16A-F553B6F92012Q34222283-CD0DEDA7-1AA6-4581-9D36-EDB191DBE2EBQ34312988-88642DC5-6DED-40ED-801D-9FA0FE2AAE37Q34753973-0FC735C0-B248-41CF-9FA9-4CD3CDF2791CQ34943906-A02301DA-553D-4CDD-9B80-3D16B3EB83AAQ35068543-2BDED029-47A3-4897-A58A-009BA6BAF0BDQ35098353-0FAA5967-FF5E-4006-AE71-23D817ADB116Q35148857-DBA35AEC-AA17-4F13-971C-CC4C06538852Q35259669-544854CC-D236-4DA3-9AC1-12AB6947D315Q35346377-F75E9AEF-2095-401E-81D3-1DAF3C07B97BQ35548567-16163E50-35F5-4AD4-9F2C-500D7F0FED27Q35711564-99EE5816-8B83-4D1D-8CC6-4CC4812C6511Q35876759-8F209231-DD13-47C3-A6EE-123444B6443CQ35996414-F7301CCE-C1EC-45C2-846D-D04E28CEAC72Q36023170-4FB370F3-FF1C-4FEC-AD09-63E9E991A065Q36034342-B74888CF-F7E4-41D4-8760-1EEF78044AE8Q36056076-34DF72A0-C324-4D9C-9679-F97593214F33
P2860
Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Impaired IRS-1/PI3-kinase sign ...... prevalence of type 2 diabetes.
@en
Impaired IRS-1/PI3-kinase sign ...... prevalence of type 2 diabetes.
@nl
type
label
Impaired IRS-1/PI3-kinase sign ...... prevalence of type 2 diabetes.
@en
Impaired IRS-1/PI3-kinase sign ...... prevalence of type 2 diabetes.
@nl
prefLabel
Impaired IRS-1/PI3-kinase sign ...... prevalence of type 2 diabetes.
@en
Impaired IRS-1/PI3-kinase sign ...... prevalence of type 2 diabetes.
@nl
P2093
P1433
P1476
Impaired IRS-1/PI3-kinase sign ...... prevalence of type 2 diabetes.
@en
P2093
David Bernstein
David Reich
Lawrence E Sapiro
Najma Begum
Serhat Aytug
P304
P356
10.1016/J.HEP.2003.09.012
P407
P577
2003-12-01T00:00:00Z